Theravance Biopharma, Inc. Inventory
Theravance Biopharma, Inc. (TBPH) had Inventory of $0 as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2019-02-28
- 2018-12-31: Inventory, Net $0.00.
- 2018-09-30: Inventory, Net $17.92M.
- 2018-06-30: Inventory, Net $17.91M.
- 2018-03-31: Inventory, Net $17.22M.
| Period end | Inventory, Net |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2018-09-30 | $17.92M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $17.91M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $17.22M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $16.83M 10-K · filed 2019-02-28 |
| 2017-09-30 | $15.26M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $12.13M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $13.21M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $12.22M 10-K · filed 2018-02-28 |
| 2016-09-30 | $12.48M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $9.81M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $9.41M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $10.01M 10-K · filed 2017-03-01 |
| 2015-09-30 | $12.14M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $12.55M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $12.34M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $12.55M 10-K · filed 2016-03-11 |
| 2014-09-30 | $15.13M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $14.76M 10-Q · filed 2014-08-14 |
| 2014-06-02 | $14.33M 10-K · filed 2017-03-01 |
| 2014-03-31 | $11.01M 10-Q · filed 2014-06-24 |
| 2013-12-31 | $10.41M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |